Greg Courville

Greg Courville

Auto-generated profile, based on publicly available information

Greg Courville

Chan Zuckerberg Biohub San Francisco , 499 Illinois St, San Francisco, CA 94158

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PLPaul M Lebel
Paul M Lebel
IJIlakkiyan Jeyakumar
Ilakkiyan Jeyakumar
MKMichelle W L Khoo
Michelle W L Khoo
JEJames Emorut
James Emorut
CCChris Charlton
Chris Charlton
RGRafael Gomez-Sjoberg
Rafael Gomez-Sjoberg
Background: Malaria diagnostic testing remains a burden on healthcare systems. Here we present Remoscope, a portable imaging cytometer that scans fresh, unstained whole blood using a custom neural network running on low-cost hardware. Remoscope performs label-free, quantitative, stage-specific detection of Plasmodium falciparum (Pf) by screening up to 2 million red blood cells (RBCs) in 1–12 min, without sample fixation, staining or slide scanning. Low-cost disposable cartridges are used to confine flowing blood to an ultrathin sheet for imaging. Methods: Performance was benchmarked in vitro by titration of cultured Pf (17.1–710 000 parasites/µl) into whole blood. A study of Remoscope's diagnostic accuracy was evaluated in a cohort of 500 individuals in eastern Uganda, comprising 601 unique clinic visits. Parallel measurements of parasitaemia were performed using Remoscope, quantitative polymerase chain reaction (qPCR) and thick blood smears. Results: Clinically, Remoscope's 10× diluted blood assay had a limit of detection with respect to qPCR of 95.1 parasites/µl, sensitivity of 83%, specificity of 96%, positive predictive value of 91% and negative predictive value of 93%. Conclusions: Remoscope's speed, accuracy, cost and ease of use address key challenges in malaria diagnosis worldwide. In this pilot study, the diagnostic accuracy approaches that of expert thick smears performed in duplication.

2 June 2026 in bioRxiv
Verified
Preprint
Open access
CLChad Liu
Chad Liu
AHAlexander Hillsley
Alexander Hillsley
MSMadhurya Sekhar
Madhurya Sekhar
CJCassidy A. Jones
Cassidy A. Jones
GSGabriel Sturm
Gabriel Sturm
MLManuel D. Leonetti
Manuel D. Leonetti
Because cells are complex dynamical systems, modeling cellular behaviors requires methods that capture how cells evolve across time, environments, and interventions. Microscopy is uniquely suited to this goal in that it can be applied to living cells in their native context. However, the phenotypic resolving power of live-cell microscopy remains incompletely characterized, particularly relative to molecular assays. Here, we present a multimodal perturbation atlas of 1,000 pooled CRISPR knockouts in A549 cells, profiled by fluorescence microscopy (39 live, 13 fixed markers), label-free phase imaging of the same live cells, and single-cell RNA sequencing (scRNA-seq). Totaling ~57 million single-cell profiles, our data yield rich cell-biological signatures that map individual gene function. We find that phase imaging matches — and, with sufficient cell coverage, exceeds — the phenotypic resolution of fluorescence imaging and scRNA-seq, while capturing higher-order pathway organization that scRNA-seq does not resolve. These results establish intrinsic morphology as a high-precision readout of cellular state, and lay a foundation for live-cell profiling of phenotypic trajectories.

13 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
PLPaul Martin Lebel
Paul Martin Lebel
IJIlakkiyan Jeyakumar
Ilakkiyan Jeyakumar
MKMichelle W.L. Khoo
Michelle W.L. Khoo
CCChris Charlton
Chris Charlton
ASAditi Saxena
Aditi Saxena
RGRafael Gomez-Sjoberg
Rafael Gomez-Sjoberg
Malaria diagnostic testing in high transmission settings remains a burden on healthcare systems. Here we present Remoscope, a portable automated imaging cytometer that scans fresh, unstained whole blood using a custom neural network on low-cost hardware. By screening up to two million red blood cells, Remoscope performs label-free quantitative stage-specific detection of Plasmodium falciparum ( Pf ) in 1-12 minutes without sample fixation, staining, or slide scanning. Flow is used to achieve high cellular throughput, with blood confined to a 4.5 µm monolayer in low-cost disposable flow cartridges. Remoscope performance was benchmarked in vitro by titration of cultured parasites into uninfected whole blood at concentrations of 17.1-710,000 parasites/µL. Counts generated by Remoscope demonstrated a linear response across the entire range. Considering drug susceptibility assays, the half-maximal effective concentration (EC50) of chloroquine (CQ) for the W2 strain of Pf was 211 nM by Remoscope, compared to 191 nM for conventional flow cytometry. Remoscope’s real-world diagnostic accuracy was evaluated in a cohort of 500 individuals in eastern Uganda, comprising 601 unique clinic visits. Parallel measurements of parasitemia were performed using Remoscope, qPCR targeting the multicopy conserved var gene acidic terminal sequence, and microscopic evaluation of Giemsa-stained thick blood smears. Remoscope’s limit of detection with respect to qPCR was 95.1 parasites/µL. At this threshold, the system had a sensitivity of 83%, specificity of 96%, Positive Predictive Value (PPV) of 91%, and a Negative Predictive Value (NPV) of 93%. Remoscope’s speed, accuracy, low cost, and ease of use address practical challenges in malaria diagnostic settings around the world. As a general imaging flow cytometer, Remoscope may also inform the development of recognition models for the diagnosis of other infectious and noninfectious blood disorders.

27 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GCGreg Courville
Greg Courville
SVShivanshi Vaid
Shivanshi Vaid
ATAlexis Toruño
Alexis Toruño
PLPaul Lebel
Paul Lebel
JCJoana P. Cabrera
Joana P. Cabrera
RGRafael Gómez-Sjöberg
Rafael Gómez-Sjöberg
Tissue culture in 96-well microplates is conventionally a tedious, highly manual process sensitive to individual technique and experimenter error. Here, we describe the Automated Cell Culture Splitter (ACCS), a system for passaging plates of adherent or suspension cells, for routine culture maintenance or specialized applications such as seeding plates for microscopy. The system is built around the Opentrons OT-2 liquid handling robot and incorporates a novel on-deck imaging-based cell counter which allows it to compensate for density disparities across a source plate and control the number of cells seeded on a per-well basis. We find this solution can cut hands-on time by 61% and the results compare favorably to our existing manual cell culture processes in terms of both seeding density precision and bio-logical outcomes, achieving a control of seeding density with a well-to-well coefficient of variation (CV) under 11%. The system is designed to be adaptable and an accessible entry point into automation for high-throughput cell culture; to that end, all of the source code and hardware designs are released under open source licenses.

1 December 2025 in PNAS Nexus
Verified
Journal Article
Open access
GCGreg Courville
Greg Courville
SVShivanshi Vaid
Shivanshi Vaid
ATAlexis Toruño
Alexis Toruño
PLPaul Lebel
Paul Lebel
JCJoana P Cabrera
Joana P Cabrera
RGRafael Gómez-Sjöberg
Rafael Gómez-Sjöberg
Tissue culture in 96-well microplates is conventionally a tedious, highly manual process sensitive to individual technique and experimenter error. Here, we describe the Automated Cell Culture Splitter, a system for passaging plates of adherent or suspension cells, for routine culture maintenance or specialized applications such as seeding plates for microscopy. The system is built around the Opentrons OT-2 liquid handling robot and incorporates a novel on-deck imaging-based cell counter which allows it to compensate for density disparities across a source plate and control the number of cells seeded on a per-well basis. We find this solution can cut hands-on time by 61% and the results compare favorably to our existing manual cell culture processes in terms of both seeding density precision and biological outcomes, achieving a control of seeding density with a well-to-well coefficient of variation under 11%. The system is designed to be adaptable and an accessible entry point into automation for high-throughput cell culture; to that end, all of the source code and hardware designs are released under open source licenses.